Trials / Conditions / Clostridium Difficile-associated Diarrhea (CDAD)

Clostridium Difficile-associated Diarrhea (CDAD)

5 registered clinical trials studyying Clostridium Difficile-associated Diarrhea (CDAD).

Status	Trial	Sponsor	Phase
Completed	A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Ora NCT02218372	Astellas Pharma Europe B.V.	Phase 3
Completed	Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Dia NCT01691248	Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 3
Completed	A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009) NCT02835118	Merck Sharp & Dohme LLC	Phase 1
Completed	A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008) NCT02835105	Merck Sharp & Dohme LLC	Phase 1
Terminated	IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff NCT00177970	University of Pittsburgh	Phase 4